Liminatus Pharma, Inc
Financing
Shares on issue
56.0M
From 26.0M in June 2025
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
1
Warrants of every class, exercise price $11.50.
Cash
under 0.1 quarters
$0 cash on hand.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-11-02 | Private placement | 260,001 | $2.50 | $650K | 8-K ↗ |
| 2026-02-17 | Public offering | 13,813,000 | $0.29 | $4.0M | 424B4 ↗ |
| 2025-05-06 | Private placement | not available | $10.00 | $15.0M | 8-K ↗ |
Also on file: a 1-for-50 reverse split, 2026-08-20 8-K ↗